Table 2.
Infant blood concentrations for PCB-153 and p,p’-DDE prenatal and postnatal exposure, estimated through pharmacokinetic modeling (ng/g lipid).
| Study | n | Prenatal PCB-153 | < LODn (%) | Postnatal PCB-153 | n | Prenatal p,p’-DDE | < LODn (%) | Postnatal p,p’-DDE | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Median | Mean ± SD | Median | Mean ± SD | Median | Mean ± SD | Median | |||||
| Duisburga | 215 | 63.6 ± 45.9 | 56.7 | 0d | 126.1 ± 98.8 | 108.7 | 215 | 141.4 ± 205.1 | 95.2 | 0d | 255.3 ± 287.6 | 178.1 |
| ELFEb | 35 | 92.6 ± 41.9 | 83.3 | 0 | 301.1 ± 133.0 | 268.1 | 0 | NA | NA | NA | NA | NA |
| FLEHS Ic | 129 | 54.0 ± 38.4 | 41.3 | 6 (4.5)d | 66.5 ± 69.6 | 47.1 | 130 | 214.7 ± 244.5 | 145.6 | 0d | 272.6 ± 412.9 | 150.6 |
| GRDc | 321 | 184.7 ± 72.9 | 176.7 | 0 | 280.4 ± 152.0 | 252.4 | 0 | NA | NA | NA | NA | NA |
| HUMISb | 399 | 36.4 ± 17.1 | 33.1 | 0d | 104.7 ± 52.2 | 96.8 | 399 | 63.4 ± 94.8 | 42.1 | 0d | 177.3 ± 236.9 | 123.1 |
| Michalovcec | 880 | 164.4 ± 219.2 | 111.2 | 2 (0.2) | 292.4 ± 425.4 | 175.3 | 880 | 540.5 ± 459.0 | 413.5 | 6 (0.7) | 954.3 ± 1032.8 | 619.6 |
| PELAGIEc | 168 | 43.0 ± 31.5 | 32.1 | 0d | 48.3 ± 55.9 | 26.2 | 168 | 73.5 ± 74.4 | 53.9 | 28 (16.4)d | 75.7 ± 99.8 | 36.6 |
| NA, not available. aPrenatal and postnatal concentrations estimated from maternal blood concentrations. bPrenatal and postnatal concentrations estimated from breast milk concentrations. cPrenatal and postnatal concentrations estimated from cord blood concentrations. dProvided LOQ instead of LOD. | ||||||||||||